Suppr超能文献

通过综合呼吸道病毒检测板测序揭示的医院空气中的严重急性呼吸综合征冠状病毒2

SARS-CoV-2 in hospital air as revealed by comprehensive respiratory viral panel sequencing.

作者信息

Habibi Nazima, Uddin Saif, Behbehani Montaha, Abdul Razzack Nasreem, Zakir Farhana, Shajan Anisha

机构信息

Environment and Life Sciences Research Center, Kuwait Institute for Scientific Research, Kuwait.

出版信息

Infect Prev Pract. 2022 Mar;4(1):100199. doi: 10.1016/j.infpip.2021.100199. Epub 2021 Dec 27.

Abstract

BACKGROUND

Nosocomially acquired severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection has become the most significant pandemic of our lifetime. Though its transmission was essentially attributed to droplets from an infected person, with recent advancements in knowledge, aerosol transmission seems to be a viable pathway, as well. Because of the lower biological load in ambient aerosol, detection of SARS-CoV-2 is challenging. A few recent attempts of sampling large aerosol volumes and using next-generation sequencing (NGS) to detect the presence of SARS-CoV-2 in the air at very low levels gave positive results. These results suggest the potential of using this technique to detect the presence of SARS-CoV-2 and use it as an early warning signal for possible outbreak or recurrence of coronavirus disease 2019 (COVID-19).

AIM

To assess efficacy of comprehensive respiratory viral panel (CRVP) sequencing and RT-PCR for low-level identification of SARS-CoV-2 and other respiratory viruses in indoor air.

METHODS

A large volume of indoor aerosol samples from three major hospitals involved in COVID-19 care in Kuwait was collected. Viral RNA was isolated and subjected to comprehensive respiratory viral panel sequencing (CRVP) as per the standard protocol to detect the SARS-CoV-2 and other respiratory viruses in the hospital aerosol and monitor variations within the sequences. RT-PCR was also employed to estimate the viral load of SARS-CoV-2.

FINDINGS

13 of 15 (86.7%) samples exhibited SARS-CoV-2 with a relative abundance of 0.2-33.3%. The co-occurrence of human adenoviruses (type C1, C2, C5, C4), respiratory syncytial virus (RSV), influenza B, and non-SARS-CoV-229E were also recorded. Alignment of SARS-CoV-2 sequences against the reference strain of Wuhan China revealed variations in the form of single nucleotide polymorphisms (SNPs-17), insertions and deletions (indels-1). These variations were predicted to create missense (16), synonymous (15), frameshift (1) and stop-gained (1) mutations with a high (2), low (15), and moderate (16) impact.

CONCLUSIONS

Our results suggest that using CRVP on a large volume aerosol sample was a valuable tool for detecting SARS-CoV-2 in indoor aerosols of health care settings. Owing to its higher sensitivity, it can be employed as a surveillance strategy in the post COVID times to act as an early warning system to possibly control future outbreaks.

摘要

背景

医院获得性严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染已成为我们有生之年最严重的大流行病。尽管其传播主要归因于感染者的飞沫,但随着知识的不断更新,气溶胶传播似乎也是一条可行的途径。由于环境气溶胶中的生物负荷较低,检测SARS-CoV-2具有挑战性。最近一些采集大量气溶胶体并使用下一代测序(NGS)技术在极低水平检测空气中SARS-CoV-2存在的尝试取得了阳性结果。这些结果表明,利用该技术检测SARS-CoV-2的存在并将其作为2019冠状病毒病(COVID-19)可能爆发或复发的早期预警信号具有潜力。

目的

评估综合呼吸道病毒检测板(CRVP)测序和逆转录聚合酶链反应(RT-PCR)在低水平鉴定室内空气中SARS-CoV-2和其他呼吸道病毒方面的效果。

方法

收集了科威特三家参与COVID-19治疗的主要医院的大量室内气溶胶体样本。按照标准方案分离病毒RNA并进行综合呼吸道病毒检测板测序(CRVP),以检测医院气溶胶体中的SARS-CoV-2和其他呼吸道病毒,并监测序列中的变异情况。还采用RT-PCR来估计SARS-CoV-2的病毒载量。

研究结果

15个样本中有13个(86.7%)检测出SARS-CoV-2,相对丰度为0.2%-33.3%。还记录到人类腺病毒(C1、C2、C5、C4型)、呼吸道合胞病毒(RSV)、乙型流感病毒和非SARS-CoV-2 29E病毒的共同存在。将SARS-CoV-2序列与中国武汉参考毒株进行比对,发现存在单核苷酸多态性(SNP-17)、插入和缺失(indel-1)形式的变异。这些变异预计会产生错义(16个)、同义(15个)、移码(1个)和截短(1个)突变,影响程度高(2个)、低(15个)和中等(16个)。

结论

我们的结果表明,对大量气溶胶体样本使用CRVP是检测医疗机构室内气溶胶体中SARS-CoV-2的一种有价值的工具。由于其较高的灵敏度,在COVID后时代可将其用作监测策略,作为早期预警系统以可能控制未来的疫情爆发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ec3/8749455/3ff9771f62b6/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验